launch stage to growth stage

goode evening

“Beta is a drug used hospital treatment of serious infections. it is a very specialized drug, and cannot be obtained from a doctor or a pharmacy for use outside a hospital environment. it was launch only 3 months ago and has yet to generate significant sales volume.

the directors can invest in Beta to promote it, which should lead to significant growth in sales of Beta. however, there is a competitor who is actively promoting a rival product with similar performance to that of Beta”

we are asked to evaluate the potential impact of investment in beta.

i made an extra point that the answer did not mention and i want to know if this is valid:

My Point: that beta is a niche product and even if takes the market share as desired by the company, it may not have the volumes and thus may not support the product portfolio in terms of cashflows or profits.

thanks